Matthew has over 20 years’ experience designing and managing observational non-interventional studies and other scientific research approaches; he has developed and led numerous successful global programs and has particular expertise in rare-disease programs. Matthew has been involved in studies that have objectives ranging from developing a better understanding of the natural history of a disease to supporting a global safety-surveillance mandate. His technical expertise includes program strategy and operational structure in disease and product registries, prospective pharmacoeconomic studies, and systematic reviews of scientific literature. Matthew is frequently published in the field of observational research and often speaks at scientific meetings about the continually evolving field of real-world research.
Prior to joining Worldwide, Matthew served as Senior Director, Observational Research, at PAREXEL, where he managed multiple clients and their late-phase research initiatives. Matthew has also held senior management roles at inVentiv Health Clinical, Outcome/Quintiles, ICON Clinical Research (formerly Ovation Research Group), and United Biosource Corporation (formerly MetaWorks, Inc.). Matthew holds a Bachelor of Arts in sociology from Boston University and is a longstanding member of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR).